Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Mucosal Barrier of the Stomach
Protection of Alcohols
Zones of Protection
Pulmonary Tuberculosis I
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 30, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Thomas J Scriba1, Elisa Nemes2
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. Thomas.scriba@uct.ac.za.
No abstract available in PubMed .
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019